ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 237677 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 237677; 2) Community: the network communities that were significantly associated with the response to NSC 237677; 3) Molecule: the relationships between components within communities and NSC 237677; 4) MDR: the compounds that were significantly associated with the NSC 237677.

NSC Compound Enrichment Correlation
NSC 645384 Null 0.00845932736945076 0.37606575
NSC 671009 2H-Thieno[3',4':4,5]cyclopent[1,2-d]oxazole- 2,7(7aH)-dione,4,6-dibromo-3,3a-dihydro- 0.00845932736945076 0.54768512
NSC 672136 9-.alpha.-Hydroxyparthenolide 0.00845932736945076 0.66103694
NSC 674347 4-(1,1-Dimethylethyl)-1-(1-methylethyl)-{9,10-dihydro-12-met hoxy-8-hydroxymethyl-9-oxoindolizo[1,2-b]quinolin-7-yl}butanedioate 0.00845932736945076 0.11900017
NSC 675766 Null 0.00845932736945076 -0.20355912
NSC 676581 Null 0.00845932736945076 0.25744043
NSC 681635 Camptothecin Derivative 0.00845932736945076 0.1171937
NSC 682840 Butanimidoyl chloride, N-[[[[4-(trifluoromethoxy)phenyl] amino]carbonyl]oxy]- 0.00845932736945076 0.51649774
NSC 684439 Null 0.00845932736945076 0.23095684
NSC 688978 Perylene-4,9-dione, 5,8-dihydroxy-1,3,10,12-tetramethoxy- 6,7-dipropyl- 0.00845932736945076 0.07839087
Total:104  Current:23    [First] [Prev] [Next] [Last]